The Amyloidosis Center at Boston University School of Medicine is an internationally recognized center of excellence, and a global resource for doctors, researchers, patients, and families.
Founded in 1960 primarily for research, the center has pioneered significant new treatments over the years, and developed, within the Boston Medical Center, the largest clinical program in the country devoted to the treatment of systemic amyloid diseases. Multidisciplinary researchers come from the School’s departments of medicine, pathology, biochemistry, and neurology, while the center’s multidisciplinary clinical team includes internists, hematologists, cardiologists, pulmonologists, gastroenterologists, neurologists, and other specialists. These basic science and clinical investigators seek to broaden our understanding of the pathobiology of misfolded protein diseases and translate these findings into new therapies.
Along with research and clinical care, the center provides diagnostic services and training for physicians and scientists in the field. The center’s reference laboratory tests for amyloid deposits in blood and tissue samples sent from medical facilities around the world. Our doctors travel widely to educate other medical professionals, scientists, patients, and families about amyloidosis. Each year, physicians and scientists visit the center to exchange ideas or undergo training in amyloidosis research.
To learn more about how you can support the work of the Amyloidosis Center, please contact the Boston University School of Medicine at 617-358-9535 or email@example.com, or visit bu.edu/amyloid.